Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Australia.
Translational Research Institute Queensland, Australia.
Gut Microbes. 2022 Jan-Dec;14(1):2132078. doi: 10.1080/19490976.2022.2132078.
Frequently, patients with functional gastrointestinal disorders (FGIDs) report intolerance of wheat products. We compared gastrointestinal symptoms, sensory function, psychiatric comorbidities, gut-homing immune cells, and duodenal mucosa-associated microbiome (d-MAM) in FGID patients and controls with and without self-reported wheat sensitivity (SR-NCWS). We recruited 40 FGID patients and 20 controls referred by GPs for treatment. Gastrointestinal/extraintestinal symptoms, visceral sensory function, psychological comorbidities, and SR-NCWS were assessed in a standardized approach. Peripheral gut homing T-cells (CD4α4β7CCR9/CD8α4β7CCR9) were quantified, and the d-MAM was assessed by DNA sequencing for 46 subjects. Factors of bacterial genera were extracted utilizing factor analysis with varimax rotation and factors univariately associated with FGID or SR-NCWS included in a subsequent multivariate analysis of variance to identify statistically independent discriminators. Anxiety scores (p < .05) and increased symptom responses to a nutrient challenge (p < .05) were univariately associated with FGID. Gut homing T-cells were increased in FGID patients with SR-NCWS compared to other groups (p all <0.05). MANOVA revealed that anxiety (p = .03), visceral sensory function (p = 0.007), and a d-MAM factor comprise members of the , and lineages were significantly (p = .001) associated with FGID, while gut homing CD4α4 β7CCR9 T-cells were associated (p = .002) with SR-NCWS. Compared to controls, patients with and without SR-NCWS show that there are shifts in the amplicon sequence variants within specific bacterial genera between the FGID subgroups (particularly and ) as well as distinct bacterial taxa discriminatory for the two different FGID subtypes. Compared to controls, both FGID patients with and without SR-NCWS have an increased symptom response to a standardized nutrient challenge and increased anxiety scores. The FGID patients with SR-NCWS - as compared to FGID without SR-NCWS (and controls without SR-NCWS) - have increased gut homing T-cells. The d-MAM profiles suggest species and strain-based variations between the two FGID subtypes and in comparison to controls.
常伴有功能性胃肠疾病(FGIDs)的患者报告对小麦产品不耐受。我们比较了 FGIDs 患者和对照者中有和无自我报告的小麦敏感(SR-NCWS)者的胃肠症状、感觉功能、精神共病、肠道归巢免疫细胞和十二指肠黏膜相关微生物组(d-MAM)。我们招募了 40 名 FGIDs 患者和 20 名由全科医生推荐接受治疗的对照者。通过标准化方法评估胃肠/肠外症状、内脏感觉功能、心理共病和 SR-NCWS。定量外周肠道归巢 T 细胞(CD4α4β7CCR9/CD8α4β7CCR9),对 46 例患者的 d-MAM 进行 DNA 测序评估。利用最大方差旋转的因子分析提取细菌属的因子,并将与 FGID 或 SR-NCWS 相关的因子纳入后续的方差分析多元回归,以确定具有统计学意义的独立判别因子。焦虑评分(p<0.05)和对营养挑战的症状反应增加(p<0.05)与 FGIDs 呈单变量相关。与其他组相比,伴有 SR-NCWS 的 FGIDs 患者的肠道归巢 T 细胞增加(p 均<0.05)。MANOVA 显示,焦虑(p=0.03)、内脏感觉功能(p=0.007)和一个 d-MAM 因子由 、 和 属的成员组成,与 FGID 显著相关(p=0.001),而肠道归巢 CD4α4β7CCR9 T 细胞与 SR-NCWS 相关(p=0.002)。与对照组相比,伴有和不伴有 SR-NCWS 的 FGID 患者显示出 FGID 亚组之间特定细菌属的扩增子序列变异以及区分两种不同 FGID 亚型的细菌分类群存在差异。与对照组相比,伴有和不伴有 SR-NCWS 的 FGID 患者对标准化营养挑战的症状反应增加,焦虑评分增加。与无 SR-NCWS 的 FGIDs 患者(和无 SR-NCWS 的对照组)相比,伴有 SR-NCWS 的 FGIDs 患者的肠道归巢 T 细胞增加。d-MAM 谱表明两种 FGIDs 亚型之间以及与对照组相比存在物种和菌株的差异。
Am J Physiol Gastrointest Liver Physiol. 2020-7-13
Dig Dis Sci. 2021-1
Front Microbiol. 2024-10-14
J Can Assoc Gastroenterol. 2023-11-24
Am J Gastroenterol. 2022-6-1
Neurogastroenterol Motil. 2022-11
Int J Mol Sci. 2021-12-19
Obesity (Silver Spring). 2022-1
Am J Gastroenterol. 2021-5-1
Dig Dis Sci. 2022-1